Healthcare Global Enterprises Ltd IPO Message Board (Page 11)

looking results of ipo its seem that SEBI ALSO TRY TO CONVERT RETAIL IPO MONEY INTO NON PERFORMING ASSETS BAD AND FRAUDY LOSS MAKING IPO

septaji i think infibeam send ecommerce items through their own couriers transport its integrated player ecommerce and transport if qib portion above 20 times then good to apply infibeam

May be

guys now as per my view healthcare global avoid and for infibeam look subscription fighure of qib and nii then apply

septaji for year 2015 and 2016 infibeam making profits or loss ? If all loss making co comes with ipo then retailer will also in loss

not necessary Mehul i do not have the data for 2015 and 2016 however i have heard mehta in one conference he said they will be in black before 2016 so i hope once red herring comes out we know the real picture

Too many its n buts in HCG IPO. At first glance the issue seems overpriced but future prospects look great. Today''s lifestyle has 2 major health problems
1) Cancer, 2) Infertility.
HCG is specialising in both n hence future looks bright. However, retailers should stay away in present scenario. However, investors with long term horizon n deep pockets can invest. Also, even if one wants to invest in this IPO, then it is advised to see QIB n NII/ FIIs subscription figures till 1300h n the last day of IPO. If demand is more from NIIs then one may apply. Remember its ur money. Invest wisely without unduly getting influenced by anyone. N after u have taken a decision then stand by it without blaming anyone. Best of luck n god speed.

BUY COAL india at Rs 260 -rs 265 only if it goes down

Let''''s see Chem cho if it goes down to 260 levels:-)

INFI 400 Application Buyerrrrrrrrrrrrrr

Avoid such high priced issue.
Long term investors add post listing.
Be aware protect your investment

Infibeam on 21st first E Com company.
From last three its making loss.

Premium 32-34 Rajkot
Application 400
Retail is 10%


Bharat wire
Avoid
No premium.


HCG
Premium 5-7.5 No volume
Application NIL@Rajkot


Upcoming IPO event
Equitas Holding Ltd. On 4th
GVR infra Project Ltd. First Week April

@Arjun Patel : Rajkot ma kaya DP ma Grey Premium open thyu 6 ?

At present kai company na ketla rates grey na chale 6 ?

at present which companies grey is opened and how much and in which dp ?

kindly guide me i am also from Rajkot so able to judge.

septaji how u rate infibeam corporation ? Is it profitable company ?

was just on call with my broker asked him abt HCG GMP he said not much interest premium is drop to single digit Rs 4- Rs 5 Eagleeye and other confirm if this is right

Premium 7-8 no volume

Infibeam Corporation Ltd.
Date: 21-23 March
Price band: 360-432 lot 34 shares
Retails 10%

Market share of infibeam is very few.....almost bellow 2%.......fingers are crossed......

Coal India likely to buyback 5% of equity from market worth 10700crores. Stock may inch upwards on the said rumor. A good buy for medium to long n very long term. Strongly recommended to have it in ones portfolio. Shivajee n star ipo especially for u both.

Rks,
U advised to buy Coal India at 320 for Rs. 27
Now stock trading at 296
Net of brokerage retailers left with nothing

Stop giving technical calls.

Urge investors to look at own risk appetite.

Dear Arjun. Buyback price of coal India is 340. Do u still advice to not put money into it? Today is ex dividend day so stock down. As oil price increase coal would be preferred choice so the prospects of coal India loom great. Also, pl do not look at 1 day fall. Coal India is worth holding for long term. As for buy call for coal India was concerned, it was for a price of 315. Read the post carefully where I mentioned it. However, the stock never reached that price. So my call got negated. Before making 2+2=5 I request u to go through the posts carefully. I respect ur judgement dear friend. However, for people interested in long term gains, the stock is available at a good price. So buy. I also recommended to buy MIC Electronics at 18. Why no one is talking about that? Share market is for opportunities. Its for one to decide he wants to take advantage of it or not.

How to start ASBA in the bank for IPO? Can any body explain me?

I think cheque submission process is no more now.

septaji yes hcg avoid so gvr infra apply and infibeam and equitas holding to consider now

septaji your view on infibeam and equitas holding please

let wait mehul mehta let now force on two issue

HCG and bharat rope

Bharat rope is out right AVOID

HCG good sector but this hub and spoke and JV may be better avoid

What I like about HCG:-

(1) Cancer specialty is a niche & fast growing segment.
(2) The Fertility segment ''BACC'' (Milaan brand) again has a high growth potential & is run by a credible person- Dr Kamini Rao (Padma Shree awardee & one of the pioneers in the field). Currently BACC contributes 8% to the top-line.

What I do not like about HCG:-

(1) Their Africa business is not by their own choice- it''s an unstated appeasement of their PE investor (CDC) who in turn has a clear mandate to help Africa in its struggle against poverty, malnutrition etc. They got 15-16% of revenues sourced from Africa, if i''m not wrong. Africa''s commodity driven economy is in the grips of current deflationary environment & therefore let''s not hope for any ''material'' growth in HCG''s African business. It might be a drag on its overall operations IMO.
(2) They have used 2 standard accounting tricks to show a 5.5M profit in FY15- DTA as well as Provision for bad debts. Adjusting for these, their losses should be in the range of 75-100M.
(3) Their centre of excellence in Bangalore (Hub) counsels their cases originated at other centres (Spokes). This (Hub & Spoke) is different from their ''organisational structure'' which entails numerous JVs/Partnerships instead of fully owned hospitals. These two aspects of their business are different- Hub & Spoke is ok but expanding business with JV/Partnerships is not Ok! They could have their own hospital chain & still refer to their CoE at Bangalore for value-added counselling.
The problem with JV/Partnerships is that often there is fraud, dispute & ,eventual separation. All of these have already happened with HCG. Nanavati is a major hospital in Mumbai & not being able to preserve tie-up with such a partner is clearly not going to help HCG. Further, HCG runs a risk of Dr Kamini exercising her ''put options'' & starting her own business.
(5) HCG is not an asset-lite business contrary to what the Hub & Spoke model would have you believe. It''s a capital intensive business with significant debt (D/E at approx 1x) with a significant gestation period. So, increase in revenues from new centres will take some time to trickle down to the bottom-line. Average Return on Capital (Net Worth) is negative implying that capital employed for top-line growth has not returned profits for the stakeholders.
(6) HCG lacks the ''affordable'' tag which IMO is very crucial for success in Indian markets. Even Apollo, which started as a hospital for well-to-do, is increasingly focusing on ''affordability''.
(7) Price to NAV is 6x, similar to Apollo (6x) but much higher than Fortis (2x).

Conclusion:- Not interested. The company is not there yet...... it doesn''t seem to be poised for a take-off........PEs seem to be desperate to exit (two of them are offloading 50% whilst the third one 33%)...... I have, therefore, not tried to come up with any intrinsic value assessment. The company could become profitable on a sustainable basis if it could utilize its high operating leverage (i.e. high fixed costs). All it needs is increase in foot-fall (patients) so that high fixed costs of its machines whether in the form of depreciation or in the form of high financing cost (interest) could be profitably recovered. "New centres" will only help increase top-line w/o much impact on bottom-line as long as they remain leveraged (operationally as well as financially). A strong brand perception and/or a shift towards making its services more ''affordable'' will increase footfall & eventually pull the company into ''black''. This can happen... it''s just that I don''t see it happening any time soon.

Neotrade when we all know BCG MATRIX now let put this theory on HCG it is not a cash cow and it is not a dog so what is left star and question mark it not a star to becamarket growth is high how every cash growth is missing so what is left is question mark for HCG..... so all this argument if the business model is great or not is a big question mark. That is reason savvy investor will avoid or wait.... u may argue risk will reward however presently market is in bear phase so it better to avoid and wait then apply and take risk.....

Even you r not sure abt its success becau said will apply only after seeing QIB interest.... For me the issue is same i will wait if QIB is over 20 times then i will apply becai like this high growth sector in many decades to come

I agree...this one offers very good risk adjusted returns...key is "risk adjusted"...and yep...Anchor is key for me here...but QIB 20x in such markets...I doubt...but even 2-3x QIB in this market with good Anchor will convert me! Its a 75% QIB issue...and fairly large one...650 cr odd...

Cancer treatments is very costly and hence patients prefer to get treatment from subsidised hospitals like Tata memorial at Parel in mumbai ,
With the inauguration of its new multi-speciality cancer institute in Thane, Jupiter Hospital, became the second private hospital to offer subsidised cancer treatment in the Mumbai/Thane region, after Parel-based Tata Memorial Hospital.

On Wednesday, state Health Minister Suresh Shetty inaugurated the Jupiter Cancer Institute''''s 21-bed economy wing, where patients will get cancer treatment at half the usual cost. Of the 21 beds in the wing, 10 will be available at Rs 300, besides 50 per cent of the routine treatment charges. Patients will have to pay Rs 600 for the rest of the beds in this wing. The Jupiter Hospital will have a total capacity of 200 beds.

Most of the states in India are having subsided treatment,
since this is an loss making company , it is of no to invest in such Ipo ,Getting stuck for an gain of Rs 25 does not make sense

Like coffee day enterprise , Quick heal Technology you money will be stuck ,

It is clear Avoid

arjunbhai infibeam ltd eps how much for last 3 yr ?

Upcoming Ipo Events
Infibeam Ltd
21-23 March
Issue Size 450 Cr.

Equitas Holding Ltd.
4-6 April
Issue Size 1700 cr.

GVR Infra Projects Ltd.
29 March
Issue Size 660 Cr.

there is nothing except loss in healthcare global why sebi give permission to fraudy ipo like pcl quick heal and healthcare global ?